Riskpilot← Back to searchSign inGet full accessTingvalla Naprapatklinik AB
ABActiveOrg 5568993603Drottninggatan 18Physiotherapy activities · NACE 8695Est. 201210-19 employees
Revenue 2025
SEK 6,7M
+14% vs 2024
EBITDA margin
12.2%
+91% vs 2024
Equity ratio
58.1%
Financial strength
Net profit 2025
SEK 475K
+63% vs 2024
| Revenue | SEK 6,7M | +14% |
| EBITDA | SEK 814K | +91% |
| Net profit | SEK 475K | +63% |
| Total assets | SEK 1,8M | +6% |
| Equity | SEK 1M | -24% |
| Employees | — | — |
Legal name
Tingvalla Naprapatklinik AB
Org number
5568993603
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
19 juli 2012
Share capital
SEK 51 000
Employees
10-19
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva naprapati, massage och andra relaterade behandlingar inom frisk och hälsovård. Bolaget skall dessutom hyra ut rum och lokaler till andra med likartad verksamhet.
Address
Drottninggatan 18
Email
ulf@naprapatklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 315 | 5 522 | 5 680 | 5 862 | 6 684 |
| Staff expenses | — | −4 188 | −4 286 | — | −4 809 |
| EBITDA | 517 | 369 | 226 | 425 | 814 |
| Depreciation & amort. | −78 | −72 | −72 | −77 | — |
| EBIT | 439 | 297 | 154 | 348 | 814 |
| Net financials | −10 | −13 | −15 | −12 | −3 |
| Profit before tax | 316 | 209 | 395 | 380 | 611 |
| Tax | −73 | −47 | −79 | −89 | −136 |
| Net profit | 243 | 162 | 316 | 291 | 475 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 880 | 2 019 | 1 812 | 1 659 | 1 764 |
| Equity | 581 | 743 | 1 059 | 1 350 | 1 025 |
| Long-term debt | 201 | 153 | 105 | 50 | 0 |
| Short-term debt | 809 | 759 | 541 | 195 | 474 |
| Total debt | 1 010 | 912 | 645 | 245 | 474 |
EBITDA margin
12.2%
This company
15.8%
Market median
-23% vs market
20212025
Equity ratio
58.1%
This company
38.2%
Market median
+52% vs market
20212025
Return on equity
46.3%
This company
18.4%
Market median
+152% vs market
20212025
Net profit margin
7.1%
This company
8.1%
Market median
-12% vs market
20212025
Asset turnover
3.79×
This company
1.12×
Market median
+238% vs market
20212025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JJ | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tingvalla Kliniken Holding AB
Tingvalla Naprapatklinik AB Board members of Tingvalla Naprapatklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Joakim Läckström | Audit | 0 companies |
| Lars-Jonas Lundquist | Deputy Board Member | 0 companies |
| John Ulf Henry Ackerblad | Board of Directors | 0 companies |
| Kajsa Elin Sofia Albrecktsson | Deputy Board Member | 0 companies |